Multiple endogenous growth factor receptors and extracellular matrix components

Multiple endogenous growth factor receptors and extracellular matrix components is a composite target designation used to describe the broad pharmacological activity of agents that influence tissue regeneration and remodeling (Source: AdisInsight). This category is not a single molecular entity but rather a functional network comprising various cell-surface receptors—such as the Epidermal Growth Factor Receptor (EGFR), Fibroblast Growth Factor Receptor (FGFR), and Platelet-Derived Growth Factor Receptor (PDGFR)—alongside structural proteins like collagen, elastin, and fibronectin (Source: StatPearls). These components work in concert to regulate essential cellular processes, including proliferation, migration, and the synthesis of the dermal matrix, which are critical for wound healing and skin maintenance (Source: Wikipedia). Drugs associated with this target profile, such as tretinoin, becaplermin, and trafermin, exert their effects by either directly activating these receptors or modulating gene expression to enhance the endogenous regenerative environment (Source: PubChem, FDA). Clinically, these agents are employed to treat conditions such as photoaging, acne, and chronic diabetic foot ulcers by promoting the restoration of healthy tissue architecture. However, because this target encompasses multiple potent signaling pathways, therapeutic use must be balanced against risks such as localized irritation, hypersensitivity, or the theoretical potential for promoting unregulated cell growth (Source: FDA).

Other names

Growth factor receptors and ECMDermal remodeling targetsPleiotropic tissue repair targets

Activation of signaling cascades through growth factor receptors (e.g., PDGFR, FGFR) and modulation of gene expression via nuclear receptors (e.g., RAR, RXR) to increase extracellular matrix production and cellular turnover (Source: PubChem, StatPearls).